نتایج جستجو برای: pravastatin

تعداد نتایج: 1688  

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2004
Shiro Kitamoto Kaku Nakano Yasuhiko Hirouchi Yoshiro Kohjimoto Shunichi Kitajima Makoto Usui Shujiro Inoue Kensuke Egashira

OBJECTIVE Anti-atherosclerotic effects of statins might be mediated partly by pleiotropic cholesterol-lowering independent mechanisms. We used nonhuman primates and examined whether treatment with pravastatin or antimonocyte chemoattractant protein-1 (MCP-1) therapy can induce regression and stabilization of established atherosclerotic lesions through cholesterol-lowering independent mechanisms...

Journal: :Lancet 2002
James Shepherd Gerard J Blauw Michael B Murphy Edward L E M Bollen Brendan M Buckley Stuart M Cobbe Ian Ford Allan Gaw Michael Hyland J Wouter Jukema Adriaan M Kamper Peter W Macfarlane A Edo Meinders John Norrie Chris J Packard Ivan J Perry David J Stott Brian J Sweeney Cillian Twomey Rudi G J Westendorp

BACKGROUND Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-aged individuals, their efficacy and safety in elderly people is not fully established. Our aim was to test the benefits of pravastatin treatment in an elderly cohort of men and women with, or at high risk of developing, cardiovascular disease and stroke. METHODS We did a randomised controlled tr...

Journal: :Antimicrobial agents and chemotherapy 2013
E G J Hulskotte H-P Feng F Xuan S Gupta M G J A van Zutven E O'Mara J A Wagner J R Butterton

Boceprevir is a potent orally administered inhibitor of hepatitis C virus and a strong, reversible inhibitor of CYP3A4, the primary metabolic pathway for many 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Thus, the aim of the present study was to investigate drug-drug interactions between atorvastatin or pravastatin and boceprevir. We conducted a single-center, open-labe...

2014
Grishma Trivedi Hasumati Raj

Pravastatin is an inhibitor of HMG-CoA reductase inhibitor which is used as a hypolipidemic agent to reduce cholesterol level. Chemically, 9-Fluoro-11β,17-dihydroxy-16α-methyl-3,20-dioxopregna-1,4-dien21-yl disodium phosphate. Pravastatin is a drug of choice for the cardiovascular disease. It reduces the coronary and cerebrovascular morbidity and mortality in middle aged individual. Elevated pl...

Journal: :Stroke 2007
Frieke M A Box Jeroen van der Grond Anton J M de Craen Inge H Palm-Meinders Rob J van der Geest J Wouter Jukema Johan H C Reiber Mark A van Buchem Gerard J Blauw

BACKGROUND AND PURPOSE Despite speculations, it is unknown whether statins affect wall shear stress (WSS). Therefore, the effect of pravastatin on WSS was investigated. METHODS In 355 elderly individuals participating in the PROSPER study (follow up after 3 years), the effect of 40 mg pravastatin on WSS was assessed in the internal carotid artery using magnetic resonance imaging. RESULTS WS...

Journal: :Atherosclerosis. Supplements 1995
James Shepherd Stuart M Cobbe Ian Ford Christopher G Isles A Ross Lorimer Peter W MacFarlane James H McKillop Christopher J Packard

BACKGROUND Lowering the blood cholesterol level may reduce the risk of coronary heart disease. This double-blind study was designed to determine whether the administration of pravastatin to men with hypercholesterolemia and no history of myocardial infarction reduced the combined incidence of nonfatal myocardial infarction and death from coronary heart disease. METHODS We randomly assigned 65...

Journal: :The Journal of pharmacology and experimental therapeutics 2009
Takao Watanabe Hiroyuki Kusuhara Kazuya Maeda Yoshihisa Shitara Yuichi Sugiyama

Hepatobiliary excretion mediated by transporters, organic anion-transporting polypeptide (OATP) 1B1 and multidrug resistance-associated protein (MRP) 2, is the major elimination pathway of an HMG-CoA reductase inhibitor, pravastatin. The present study examined the effects of changes in the transporter activities on the systemic and liver exposure of pravastatin using a physiologically based pha...

Journal: :American journal of physiology. Heart and circulatory physiology 2005
Tsung-Ming Lee Mei-Shu Lin Tsai-Fwu Chou Chang-Her Tsai Nen-Chung Chang

Endothelin (ET)-1 has been implicated in the development of cardiac hypertrophy. We investigated the effect of pravastatin on development of ventricular hypertrophy in spontaneously hypertensive rats (SHR) and whether the attenuated hypertrophic effect was via reduced ET-1 expression. Normolipidemic SHR were treated with one of the following therapies for 8 wk: vehicle, the nonselective ET rece...

Journal: :Lancet 2002

BACKGROUND The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study showed that pravastatin therapy over 6 years reduced mortality and cardiovascular events in patients with previous acute coronary syndromes and average cholesterol concentrations. We assessed the longer-term effects of initial treatment with pravastatin on further cardiovascular events and mortality over a...

2018
Masatoshi Koga Kazunori Toyoda Kazuo Minematsu Masahiro Yasaka Yoji Nagai Shiro Aoki Tomohisa Nezu Naohisa Hosomi Tatsuo Kagimura Hideki Origasa Kenji Kamiyama Rieko Suzuki Toshiho Ohtsuki Hirofumi Maruyama Kazuo Kitagawa Shinichiro Uchiyama Masayasu Matsumoto

BACKGROUND AND PURPOSE The effect of statins on progression of carotid intima-media complex thickness (IMT) has been shown exclusively in nonstroke Western patients. This study aimed to determine the effect of low-dose pravastatin on carotid IMT in Japanese patients with noncardioembolic ischemic stroke. METHODS This is a substudy of the J-STARS trial (Japan Statin Treatment Against Recurrent...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید